Table 4 Summary of AEs
| Â | BM-MSC | Placebo |
|---|---|---|
| Â | No. of patients | No. of patients |
| Â | (No. of events) | (No. of events) |
System organ class | ||
At least one symptom | 6 (13) | 7 (45) |
  Gastrointestinal disorders | 1 (1) | 2 (2) |
  General disorders and administration site conditions | 3 (3) | 0 |
  Hepatobiliary disorders | 0 | 1 (1) |
  Infections and infestations | 3 (3) | 3 (3) |
  Injury, poisoning and procedural complications | 1 (1) | 1 (2) |
  Investigations | 1 (2) | 3 (29) |
  Metabolism and nutrition disorders | 0 | 1 (1) |
  Musculoskeletal and connective tissue disorders | 0 | 1 (2) |
  Nervous system disorders | 0 | 2 (3) |
  Psychiatric disorders | 0 | 1 (1) |
  Renal and urinary disorders |  | 1 (1) |
  Skin and subcutaneous tissue disorders | 1 (1) | 0 |
  Vascular disorders | 1 (2) | 0 |